Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 1
1961 1
1962 2
1963 9
1964 2
1965 2
1968 3
1969 1
1971 3
1972 1
1974 2
1975 1
1976 4
1977 3
1979 3
1980 1
1982 1
1984 3
1987 2
1988 3
1989 2
1995 2
1996 1
2000 1
2001 1
2002 1
2003 1
2005 1
2006 2
2007 3
2010 4
2011 5
2012 11
2013 2
2014 3
2015 4
2016 6
2017 10
2018 7
2019 7
2020 8
2021 16
2022 7
2023 13
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

160 results

Results by year

Filters applied: . Clear all
Page 1
Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis.
Gordon KB, Blauvelt A, Papp KA, Langley RG, Luger T, Ohtsuki M, Reich K, Amato D, Ball SG, Braun DK, Cameron GS, Erickson J, Konrad RJ, Muram TM, Nickoloff BJ, Osuntokun OO, Secrest RJ, Zhao F, Mallbris L, Leonardi CL; UNCOVER-1 Study Group; UNCOVER-2 Study Group; UNCOVER-3 Study Group. Gordon KB, et al. N Engl J Med. 2016 Jul 28;375(4):345-56. doi: 10.1056/NEJMoa1512711. Epub 2016 Jun 8. N Engl J Med. 2016. PMID: 27299809 Free article. Clinical Trial.
Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials.
Griffiths CE, Reich K, Lebwohl M, van de Kerkhof P, Paul C, Menter A, Cameron GS, Erickson J, Zhang L, Secrest RJ, Ball S, Braun DK, Osuntokun OO, Heffernan MP, Nickoloff BJ, Papp K; UNCOVER-2 and UNCOVER-3 investigators. Griffiths CE, et al. Lancet. 2015 Aug 8;386(9993):541-51. doi: 10.1016/S0140-6736(15)60125-8. Epub 2015 Jun 10. Lancet. 2015. PMID: 26072109 Clinical Trial.
Photocatalytic active ZnO1-xSx@CNTs heteronanostructures.
Bjelajac A, Florea I, Zamfir M, Nenez ST, Cojocaru CS. Bjelajac A, et al. Among authors: florea i. Nanotechnology. 2023 Sep 25;34(49). doi: 10.1088/1361-6528/acf6c8. Nanotechnology. 2023. PMID: 37669662
Grid batch-dependent tuning of glow discharge parameters.
Kazan R, Bourgeois G, Carisetti D, Florea I, Larquet E, Maurice JL, Mechulam Y, Ozanam F, Schmitt E, Coureux PD. Kazan R, et al. Among authors: florea i. Front Mol Biosci. 2022 Aug 18;9:910218. doi: 10.3389/fmolb.2022.910218. eCollection 2022. Front Mol Biosci. 2022. PMID: 36060254 Free PMC article.
160 results